Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Jazz Pharma Plc (JAZZ)

Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,359,216
  • Shares Outstanding, K 60,765
  • Annual Sales, $ 4,069 M
  • Annual Income, $ 560,120 K
  • EBIT $ 150 M
  • EBITDA $ 810 M
  • 60-Month Beta 0.30
  • Price/Sales 2.55
  • Price/Cash Flow 5.63
  • Price/Book 2.62

Options Overview Details

View History
  • Implied Volatility 38.30% (+2.33%)
  • Historical Volatility 61.54%
  • IV Percentile 49%
  • IV Rank 37.24%
  • IV High 69.53% on 08/05/25
  • IV Low 19.77% on 01/21/25
  • Expected Move (DTE 19) 10.52 (6.17%)
  • Put/Call Vol Ratio 0.96
  • Today's Volume 51
  • Volume Avg (30-Day) 527
  • Put/Call OI Ratio 0.26
  • Today's Open Interest 13,352
  • Open Int (30-Day) 18,420
  • Expected Range 159.96 to 181.00

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 5.41
  • Number of Estimates 7
  • High Estimate 5.79
  • Low Estimate 5.09
  • Prior Year 5.70
  • Growth Rate Est. (year over year) -5.09%

Price Performance

See More
Period Period Low Period High Performance
1-Month
161.00 +5.89%
on 12/10/25
177.70 -4.06%
on 11/28/25
-6.44 (-3.64%)
since 11/26/25
3-Month
125.79 +35.53%
on 09/29/25
182.99 -6.84%
on 11/18/25
+43.48 (+34.24%)
since 09/26/25
52-Week
95.49 +78.53%
on 04/09/25
182.99 -6.84%
on 11/18/25
+44.66 (+35.50%)
since 12/26/24

Most Recent Stories

More News
3 Mid-Cap Stocks with Warning Signs

3 Mid-Cap Stocks with Warning Signs

GL : 142.21 (-0.90%)
JAZZ : 170.48 (-0.19%)
CNC : 40.51 (+1.55%)
3 Reasons JAZZ is Risky and 1 Stock to Buy Instead

3 Reasons JAZZ is Risky and 1 Stock to Buy Instead

JAZZ : 170.48 (-0.19%)
Jazz Pharmaceuticals to Participate in Upcoming Investor Events

DUBLIN , Dec. 17, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the following investor events:

JAZZ : 170.48 (-0.19%)
3 Value Stocks We’re Skeptical Of

3 Value Stocks We’re Skeptical Of

JAZZ : 170.48 (-0.19%)
BAND : 15.20 (+0.93%)
FDX : 296.33 (+0.15%)
Jazz Pharmaceuticals to Present Extensive New Data and Real-World Evidence Highlighting Epidiolex® (cannabidiol) Outcomes in Treatment-Resistant Epilepsies at the American Epilepsy Society 2025 Annual Meeting

New interim results from the EpiCom trial, a prospective evaluation of behavioral outcomes in patients with tuberous sclerosis complex, suggest improvements in non-seizure outcomes

JAZZ : 170.48 (-0.19%)
3 Healthcare Stocks We’re Skeptical Of

3 Healthcare Stocks We’re Skeptical Of

JAZZ : 170.48 (-0.19%)
AZTA : 34.75 (+0.70%)
AMRX : 12.95 (+0.62%)
Jazz Pharmaceuticals to Present Pivotal Phase 3 Results of Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma at the 2026 ASCO Gastrointestinal Cancers Symposium

Late-breaking HERIZON-GEA-01 presentation highlights the expanding clinical profile of Ziihera across HER2-driven gastrointestinal cancers

JAZZ : 170.48 (-0.19%)
Jazz Pharmaceuticals to Participate in Citi's 2025 Global Healthcare Conference

DUBLIN , Nov. 18, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in Citi's 2025 Global Healthcare Conference. Company management will...

JAZZ : 170.48 (-0.19%)
Stocks making big moves yesterday: Dycom, ACV Auctions, Jazz Pharmaceuticals, Coinbase, and Gibraltar

Stocks making big moves yesterday: Dycom, ACV Auctions, Jazz Pharmaceuticals, Coinbase, and Gibraltar

ACVA : 8.26 (unch)
ROCK : 50.84 (+1.48%)
DY : 347.63 (-0.22%)
JAZZ : 170.48 (-0.19%)
COIN : 236.90 (-1.18%)
3 of Wall Street’s Favorite Stocks Walking a Fine Line

3 of Wall Street’s Favorite Stocks Walking a Fine Line

NNBR : 1.3600 (+14.29%)
JAZZ : 170.48 (-0.19%)
LEG : 11.05 (+1.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Jazz Pharmaceuticals is a specialty biopharmaceutical company with a focus in the areas of neuroscience & oncology. It derives the majority of its revenues from its sleep disorder drugs' Xywav & Xyrem. Both drugs are approved for treating cataplexy & excessive daytime sleepiness in narcolepsy patients....

See More

Key Turning Points

3rd Resistance Point 172.91
2nd Resistance Point 171.92
1st Resistance Point 171.20
Last Price 170.48
1st Support Level 169.49
2nd Support Level 168.50
3rd Support Level 167.78

See More

52-Week High 182.99
Last Price 170.48
Fibonacci 61.8% 149.57
Fibonacci 50% 139.24
Fibonacci 38.2% 128.91
52-Week Low 95.49

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar